Summary

Medical Propellants Market Research Report Information By Type (HFA 134A, HFA 227EA, HFA152A), By Application (Press Metered Dose Inhalers, Breath Actuated Metered Dose Inhalers), By End User (Medical Device Companies, Contract Manufacturing Organization (CMO), and Research Laboratories) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) Market Forecast Till 2032
Market Overview
In 2023, the Medical Propellants Market was valued at USD 0.27 billion. The sector is expected to increase from USD 0.30 billion in 2024 to USD 0.72 billion by 2032, with a compound yearly growth rate (CAGR) of 10.16% for the forecast period (2024-2032). The increased prevalence of respiratory disorders such as asthma and chronic obstructive pulmonary disease, together with technological improvements in inhalation devices, are driving the global metered-dose inhaler market.
The rising frequency of respiratory illnesses, such as asthma and chronic obstructive pulmonary disease (COPD), is predicted to have a significant impact on the medical propellants industry. This effect is mostly caused by an increase in demand for inhalation-based therapies and devices that require propellants. As respiratory ailments become more widespread, so does the demand for inhalers, which are critical equipment for administering medication to the lungs. These inhalers use propellants to appropriately administer medication.

Market Segment insights
The Medical Propellants Market is divided into three types: HFA-134A, HFA-227EA, and HFA-152A.
The Market is divided into two segments based on application: manual metered dosage inhalers and breath metered dose inhalers.
The market has been divided into three segments based on end users: medical device businesses, contract manufacturing organizations (CMOs), and research laboratories.

Regional insights
North America held the biggest market share in 2023. However, Europe is expected to develop at the greatest CAGR throughout the forecast period, 2024-2032.
The Medical Propellants market in North America is expanding rapidly, owing to technical developments, a favorable regulatory environment, and rising healthcare demands. Furthermore, the market is driven by sophisticated healthcare infrastructure and significant investment in R&D, which allows for the development of cutting-edge Medical Propellants.
The Americas region is followed by Europe, which is further divided into Germany, France, the United Kingdom, Italy, Spain, and the Rest of Europe. The Medical Propellants market in Europe is characterized by ongoing innovation in propellant formulation. A mature pharmaceutical business in Europe ensures robust distribution channels and cooperation, as well as compliance with tough European laws that assure high safety and efficacy standards, building customer confidence. The rising prevalence of respiratory disorders, fueled by an aging population, heightens the demand for advanced, high-quality inhalers.
Asia-Pacific is likely to grow significantly, becoming the fastest growing region throughout the forecast period, with substantial growth driven by a number of major factors. Rapidly expanding healthcare infrastructure and increased investment in healthcare infrastructure in countries such as China, India, and Japan are driving demand for sophisticated inhalers that use medicinal propellants.

Major Players
Koura (US), SRF (India), DAIKIN (Japan), Linde PLC (UK), Xiamen Juda Chemical & Equipment Co., Ltd. (China), Jiangsu July Chemical Co., Ltd. (China), Beijing Yuji Technology Development Co., Ltd. (China), Zhejiang Jushen New Material Technology Co., Ltd. (China), Zhejiang fotech international co., ltd. (China), and Changshu 3F Fluorochemical Industry Co., Ltd.

ページTOPに戻る

Table of Contents

TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
A propellant is a substance used to propel a medication from an aerosol canister or inhaler. These propellants are typically gases that help deliver medication in a fine mist or spray to ensure it can be effectively inhaled or applied.
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
3.1 OVERVIEW
3.2 DATA FLOW
3.2.1 Data Mining Process
3.3 PURCHASED DATABASE:
3.4 SECONDARY SOURCES:
3.4.1 Secondary Research data flow:
3.5 PRIMARY RESEARCH:
3.5.1 Primary Research DATA FLOW:
3.6 APPROACHES FOR MARKET SIZE ESTIMATION:
3.6.1 Revenue Analysis Approach
3.7 DATA FORECASTING
3.7.1 Data forecasting Type
3.8 DATA MODELING
3.8.1 microeconomic factor analysis:
3.8.2 Data modeling:
3.9 TEAMS AND ANALYST CONTRIBUTION
4 MARKET DYNAMICS
4.1 INTRODUCTION
4.2 DRIVERS
4.2.1 Rising incidence of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD)
4.2.2 Technological Advancements in Inhalation Devices
4.2.3 Increased awareness about preventive healthcare
4.3 RESTRAINTS
4.3.1 High costs of advanced propellants
4.4 OPPORTUNITY
4.4.1 Emerging markets offer significant growth opportunities
5 MARKET FACTOR ANALYSIS
5.1 PORTER'S FIVE FORCES MODEL
5.1.1 Threat of New Entrants
5.1.2 BARGAINING POWER OF SUPPLIERS
5.1.3 Threat of Substitutes
5.1.4 Bargaining Power of Buyers
5.1.5 Intensity of Rivalry
5.2 IMPACT OF COVID-19 ON THE GLOBAL MEDICAL PROPELLANTS MARKET
6 GLOBAL MEDICAL PROPELLANTS MARKET, BY TYPE
6.1 OVERVIEW
6.2 HFA 134A
6.3 HFA 227EA
6.4 HFA-152A
7 GLOBAL MEDICAL PROPELLANTS MARKET, BY APPLICATION
7.1 OVERVIEW
7.2 PRESS METERED DOSE INHALERS
7.3 BREATH ACTUATED METERED DOSE INHALERS
8 GLOBAL MEDICAL PROPELLANTS MARKET, BY END USER
8.1 OVERVIEW
8.2 MEDICAL DEVICE COMPANIES
8.3 CONTRACT MANUFACTURING ORGANIZATION (CMO)
8.4 RESEARCH LABORATORIES
9 GLOBAL MEDICAL PROPELLANTS MARKET, BY REGION
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 us
9.2.2 canada
9.3 EUROPE
9.3.1 Germany
9.3.2 France
9.3.3 UK
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 ASIA-PACIFIC
9.4.1 China
9.4.2 India
9.4.3 Japan
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia-Pacific
9.5 REST OF THE WORLD
9.5.1 middle east & africa
9.5.2 south america
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 MARKET SHARE ANALYSIS, 2023
10.3 COMPETITOR DASHBOARD
10.4 PUBLIC PLAYERS STOCK SUMMARY
10.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL
10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES
10.6.1 Facility expansion
11 COMPANY PROFILES
11.1 KOURA
11.1.1 COMPANY OVERVIEW
11.1.2 FINANCIAL OVERVIEW
11.1.3 products OFFERED
11.1.4 KEY DEVELOPMENTS
11.1.5 SWOT ANALYSIS
11.1.6 KEY STRATEGIES
11.2 SRF
11.2.1 COMPANY OVERVIEW
11.2.2 FINANCIAL OVERVIEW
11.2.3 Product OFFERed
11.2.4 KEY DEVELOPMENTS
11.2.5 KEY STRATEGIES
11.3 DAIKIN CHEMICAL EUROPE GMBH
11.3.1 COMPANY OVERVIEW
11.3.2 FINANCIAL OVERVIEW
11.3.3 productS OFFERED
11.3.4 KEY DEVELOPMENTS
11.3.5 KEY STRATEGIES
11.4 LINDE PLC
11.4.1 COMPANY OVERVIEW
11.4.2 FINANCIAL OVERVIEW
11.4.3 productS OFFERED
11.4.4 KEY DEVELOPMENTS
11.4.5 SWOT ANALYSIS
11.4.6 KEY STRATEGIES
11.5 XIAMEN JUDA CHEMICAL & EQUIPMENT CO., LTD
11.5.1 COMPANY OVERVIEW
11.5.2 FINANCIAL OVERVIEW
11.5.3 PRODUCTS OFFERED
11.5.4 KEY DEVELOPMENTS
11.5.5 SWOT ANALYSIS
11.5.6 KEY STRATEGIES
11.6 JIANGSU JULY CHEMICAL CO., LTD.
11.6.1 COMPANY OVERVIEw
11.6.2 FINANCIAL OVERVIEW
11.6.3 Product OFFERed
11.6.4 KEY DEVELOPMENTS
11.6.5 KEY STRATEGIES
11.7 BEIJING YUJI TECHNOLOGY DEVELOPMENT CO., LTD.
11.7.1 COMPANY OVERVIEW
11.7.2 FINANCIAL OVERVIEW
11.7.3 PRODUCTS OFFERED
11.7.4 KEY DEVELOPMENTS
11.7.5 SWOT ANALYSIS
11.7.6 KEY STRATEGIES
11.8 ZHEJIANG JUSHEN NEW MATERIAL TECHNOLOGY CO., LTD.
11.8.1 COMPANY OVERVIEW
11.8.2 FINANCIAL OVERVIEW
11.8.3 Product OFFERed
11.8.4 KEY DEVELOPMENTS
11.8.5 KEY STRATEGIES
11.9 ZHEJIANG FOTECH INTERNATIONAL CO., LTD
11.9.1 COMPANY OVERVIEW
11.9.2 FINANCIAL OVERVIEW
11.9.3 Product OFFERed
11.9.4 KEY DEVELOPMENTS
11.9.5 SWOT ANALYSIS
11.9.6 KEY STRATEGIES
11.10 CHANGSHU 3F FLUOROCHEMICAL INDUSTRY CO., LTD.
11.10.1 COMPANY OVERVIEW
11.10.2 FINANCIAL OVERVIEW
11.10.3 Product OFFERed
11.10.4 KEY DEVELOPMENTS
11.10.5 KEY STRATEGIES
12 DATA CITATIONS